Seelos Therapeutics Inc (NASDAQ: SEEL) kicked off on November 17, 2023, at the price of $0.1239, up 1.36% from the previous trading day. During the day, the shares moved up to $0.131 and dropped to $0.1165 before settling in for the closing price of $0.12. Over the past 52 weeks, SEEL has traded in a range of $0.11-$1.66.
Elon Musk just Triggered a BOOM in These Stocks
Something strange is happening in the stock market…. This select group of stocks are going absolutely bananas. And it's all because of Elon Musk. Get your copy of "Top 5 Tech Stocks to Buy in 2024"
Click Here to Download the FREE Report.
Sponsored
Annual sales at Healthcare sector company slipped by -20.00% over the past five years. While this was happening, its average annual earnings per share was recorded 51.28%. With a float of $157.88 million, this company’s outstanding shares have now reached $161.38 million.
Let’s look at the performance matrix of the company that is accounted for 16 employees.
Seelos Therapeutics Inc (SEEL) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Seelos Therapeutics Inc is 2.17%, while institutional ownership is 23.63%.
Seelos Therapeutics Inc (SEEL) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 9/29/2023, the organization reported -$0.12 earnings per share (EPS), lower than consensus estimate (set at -$0.06) by -$0.06. This company achieved a return on equity of -314.84. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.06 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 51.28% per share during the next fiscal year.
Seelos Therapeutics Inc (NASDAQ: SEEL) Trading Performance Indicators
Take a look at Seelos Therapeutics Inc’s (SEEL) current performance indicators. Last quarter, stock had a quick ratio of 0.18. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 13.17.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.45, a number that is poised to hit -0.12 in the next quarter and is forecasted to reach -0.31 in one year’s time.
Technical Analysis of Seelos Therapeutics Inc (SEEL)
Seelos Therapeutics Inc (NASDAQ: SEEL) saw its 5-day average volume 4.09 million, a positive change from its year-to-date volume of 2.01 million. As of the previous 9 days, the stock’s Stochastic %D was 22.65%. Additionally, its Average True Range was 0.02.
During the past 100 days, Seelos Therapeutics Inc’s (SEEL) raw stochastic average was set at 1.29%, which indicates a significant decrease from 23.95% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 89.19% in the past 14 days, which was lower than the 222.29% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.2873, while its 200-day Moving Average is $0.8047. Nevertheless, the first resistance level for the watch stands at $0.1328 in the near term. At $0.1392, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.1473. If the price goes on to break the first support level at $0.1183, it is likely to go to the next support level at $0.1102. Assuming the price breaks the second support level, the third support level stands at $0.1038.
Seelos Therapeutics Inc (NASDAQ: SEEL) Key Stats
The company with the Market Capitalisation of 20.41 million has total of 127,891K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -73,530 K annual income. Company’s last quarter sales were recorded 340 K and last quarter income was -29,500 K.